Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v4-EN
Language English English
Date Updated 2022-10-20 2022-10-19
Drug Identification Number 00521515 00521515
Brand name VITAMIN B12 VITAMIN B12
Common or Proper name VITAMIN B12 VITAMIN B12
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients VITAMIN B12 VITAMIN B12
Strength(s) 1000MCG 1000MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size 1ML 10LIAM 1ML 10LIAM
ATC code B03BA B03BA
ATC description VITAMIN B12 AND FOLIC ACID VITAMIN B12 AND FOLIC ACID
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-04 2022-10-04
Estimated end date 2022-10-14 2022-10-14
Actual end date 2022-10-19 2022-10-19
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments